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Abstract
Pregnancy and childbirth represent a critical time period when a woman can be reached through a variety of 
mechanisms with interventions aimed at reducing her risk of a preterm birth and improving her health and the health 
of her unborn baby. These mechanisms include the range of services delivered during antenatal care for all pregnant 
women and women at high risk of preterm birth, services provided to manage preterm labour, and workplace, 
professional and other supportive policies that promote safe motherhood and universal access to care before, during 
and after pregnancy. The aim of this paper is to present the latest information about available interventions that can 
be delivered during pregnancy to reduce preterm birth rates and improve the health outcomes of the premature 
baby, and to identify data gaps. The paper also focuses on promising avenues of research on the pregnancy period 
that will contribute to a better understanding of the causes of preterm birth and ability to design interventions at 
the policy, health care system and community levels. At minimum, countries need to ensure equitable access to 
comprehensive antenatal care, quality childbirth services and emergency obstetric care. Antenatal care services 
should include screening for and management of women at high risk of preterm birth, screening for and treatment 
of infections, and nutritional support and counselling. Health workers need to be trained and equipped to provide 
eff ective and timely clinical management of women in preterm labour to improve the survival chances of the preterm 
baby. Implementation strategies must be developed to increase the uptake by providers of proven interventions such 
as antenatal corticosteroids and to reduce harmful practices such as non-medically indicated inductions of labour 
and caesarean births before 39 weeks of gestation. Behavioural and community-based interventions that can lead 
to reductions in smoking and violence against women need to be implemented in conjunction with antenatal care 
models that promote women’s empowerment as a strategy for reducing preterm delivery. The global community 
needs to support more discovery research on normal and abnormal pregnancies to facilitate the development of 
preventive interventions for universal application. As new evidence is generated, resources need to be allocated to its 
translation into new and better screening and diagnostic tools, and other interventions aimed at saving maternal and 
newborn lives that can be brought to scale in all countries.
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The pregnancy period and childbirth – a critical 
window of opportunity
Pregnancy and childbirth represent a critical window of 
opportunity for providing eﬀ ective interventions to 
prevent preterm birth and other adverse health outcomes 
associated with an early birth. Th ese interventions 
encompass services delivered during antenatal care for all 
pregnant women and women at high risk of preterm 
birth, services provided to manage preterm labour, and 
interventions targeted at improving health behaviours 
and knowledge about early warning signs of pregnancy 
complications, including preterm labour. Th ey also 
include the provision of needed social and ﬁ nancial 
support to disadvantaged mothers as well as workplace, 
professional and other supportive policies promoting safe 
motherhood and women’s universal access to care before, 
during, and after pregnancy.
Th is paper is based on chapter four in the Born Too 
Soon Global Action Report on Preterm Birth launched in 
May, 2012 [1] and is part of a series entitled “Born Too 
Soon”. Th e aim of the paper is to provide a summary of 
latest information about available interventions that can 
be delivered during pregnancy to reduce preterm birth 
rates and improve the health outcomes of the premature 
baby. A second objective is to describe promising avenues 
of research on the pregnancy period that will contribute 
to a better understanding of the causes of preterm birth 
and ability to design interventions at the policy, health 
care system and community levels for scale-up. An action 
agenda is proposed outlining opportunities for scaling up 
eﬀ ective interventions in low- and middle-income coun-
tries and identifying priority research themes that will 
ultimately translate into the development of preventive 
and treatment interventions for universal application.
Exhaustive systematic reviews on preterm birth inter-
ventions for the pregnancy period serve as the source of 
information for the interventions or intervention areas 
described with proven or potential eﬀ ectiveness in either 
reducing preterm birth rates or improving birth out-
comes for the premature baby [2-11] including the 
Cochrane database (Th e Cochrane Collaboration, 2013), 
which includes regularly updated systematic reviews on 
avail able evidence from clinical trials, considered the 
most robust evidence for guiding policy and programme 
develop ment. Additional articles used to support state-
ments made throughout the paper were identiﬁ ed 
through PubMed and Google Scholar.
Blencowe and colleagues describe in detail the complex 
risk factors and multiple mechanisms believed respon-
sible for the two types of preterm delivery, spontaneous 
and indicated, which includes possible epigenetic/genetic 
predispositions [12]. Advancements in the ﬁ eld of epi-
genetics have found links between fetal methylation of 
genes and the preterm birth pathway [13]. Th e majority 
of preterm births occur spontaneously, often following 
Preterm Premature Rupture of the Membranes (pPROM). 
Medically and non-medically indicated preterm births 
are related to early induction of labour or caesarean birth. 
Medical indications include pregnancy complications 
such as placental abnormalities (e.g., placenta previa), 
multiple gestations, maternal diabetes, pre-eclampsia 
and pre-existing conditions such as high blood pressure, 
asthma, thyroid and heart disease. Strategies for 
preventing or managing spontaneous and indicated types 
of preterm birth during the pregnancy period may diﬀ er 
due to variances in their underlying pathophysiological 
processes. Similarly, and for the same reason, clinical 
management of pre-existing conditions that may be 
exacerbated by pregnancy may diﬀ er from strategies used 
to address complications that develop during the preg-
nancy period. Th ere are a large number of preventive 
interventions for spontaneous and indicated types of 
preterm birth that are currently part of the standard of 
care in high-income countries. Many of these inter-
ventions are not readily available or feasible to introduce 
in low- and middle-income countries, and supportive 
evidence of their eﬀ ectiveness is lacking [14].
Available and proposed preterm birth interventions are 
tailored for delivery to three population groups: (1)  all 
pregnant women; (2) pregnant women with a history of 
previous preterm delivery or other risk factors, including 
multiple gestation, bleeding during pregnancy, hyper-
tensive disorders and diabetes; and (3) pregnant women 
experiencing or recovering from preterm labour. Inter-
ven tions for the ﬁ rst two population groups are aimed 
primarily at prevention and range from basic and special-
ized packages of antenatal care services as well as 
supportive workplace and professional policies. Interven-
tions designed for the third group are focused on 
improving the health outcomes of the premature baby. At 
the individual level, quality clinical management involves 
practitioners identifying each woman’s own set of risk 
factors throughout the pregnancy and childbirth periods 
and responding with appropriate care.
Th is paper is divided into several sections. Th e ﬁ rst 
section describes services that can be provided during 
antenatal care visits to all women and to women at high 
risk of preterm delivery, and services that can be 
delivered to women experiencing preterm labour. Th e 
next section presents information on interventions that 
can be provided at the community level and in the policy 
arena to prevent preterm birth and improve obstetric 
outcomes for women and their babies. Table  1 
summarizes the supportive policy and community 
measures that can be introduced, and the type of 
evidence-based services that can be provided during 
antenatal care and when a woman is experiencing 
preterm labour.
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Following a short section on data limitations, the last 
section explores an action agenda, describing oppor-
tunities for scaling up programmes, identifying priority 
research themes, and listing a set of steps countries can 
introduce now to address the growing problem of 
preterm birth.
Section I. Delivering eff ective care to women 
during pregnancy and preterm labour
Increasing access to care during pregnancy for all women 
is an essential step towards addressing the growing 
problem of preterm birth. Research has shown that 
women who receive antenatal care services are at lower 
risk for having a preterm birth than women who are not 
reached by the health system prior to delivery [15]. 
Further studies are needed to determine if this asso-
ciation is related primarily to the timing, number, and 
content of services provided during antenatal care visits, 
or to diﬀ erences between women who do and do not 
receive antenatal care [16,17].
Many countries around the world report high coverage 
levels of antenatal care, making antenatal care visits an 
opportune time to deliver proven interventions to all 
pregnant women) [18]. Yet, there are large and 
unacceptable inequities in coverage between and within 
counties that need to be addressed. It is critical that all 
pregnant women receive at least the basic package of 
recommended antenatal care services for their own 
health and the health of their unborn babies. Th is section 
describes services that can be provided during antenatal 
care to all women, and to women at high risk of a preterm 
birth. It also describes eﬀ ective services that can be 
provided to women experiencing preterm labour to 
improve the survival chances of the newborn.
Antenatal care services for prevention of preterm birth for 
all women
Eﬀ ective and culturally appropriate care during preg-
nancy is essential for increasing the likelihood of positive 
birth outcomes [19]. Antenatal care is a service delivery 
platform through which all women can be reached at 
multiple times during pregnancy with a package of inter-
ventions that can prolong a healthy pregnancy and 
improve maternal and perinatal health. Basic services 
that can be delivered during antenatal care with a 
potential impact on reducing preterm birth rates include 
Table 1. Priority evidence-based interventions during pregnancy to reduce preterm birth rates and to benefi t the 
premature baby
Services delivered during antenatal care: 
• Basic package for all pregnant women
• Situational interventions for populations of women at high exposure risk (e.g. identifi cation and treatment of malaria, tuberculosis and HIV)
• Behavioural, social support and fi nancial interventions for disadvantaged women
Management of pregnant women at higher risk of preterm birth including: 
• Identifi cation and treatment of pre-existing conditions (e.g., diabetes, thyroid disease, heart disease, asthma and other chronic conditions)
• Identifi cation and treatment of pregnancy complications (e.g., pre-eclampsia, antepartum haemorrhage)
• Monitoring multiple pregnancies
• Administration of progesterone to prolong pregnancy
• Identifi cation and treatment of structural abnormalities (e.g., cervical cerclage, cervical pessary)
Management of women in preterm labour including: 
• Tocolytics to slow down labour
• Antenatal corticosteroids to reduce mortality in the newborn
• Antibiotics for pPROM to prevent infection
• Provision of magnesium sulphate for neuro-protection of the newborn
Community interventions:
• Promote antenatal and skilled birth care for all women
• Smoking cessation programmes
• Reductions in exposure to secondhand smoke and other pollutants
Policy interventions:
• Policies to support safe motherhood and universal access to antenatal care
• Workplace policies regulating working hours and strenuous working conditions
• Professional and hospital policies to regulate infertility treatments and to reduce caesarean section rates and early induction of labour
Source: Born Too Soon report [1].
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identiﬁ cation of women at high risk of pretermbirth; 
screening for and treatment of sexually transmitted 
diseases including HIV and other infections (tuber cu-
losis, malaria, bacterial vaginosis, bacteriuria); identiﬁ  ca-
tion and correction of malnutrition and nutrition coun-
selling including on multiple micro-nutrient supplemen-
tation; counselling on birth preparedness and compli-
cation readiness for identiﬁ cation of early labour and 
other risk factors; and behavioural and social support 
interventions such as smoking cessation programmes 
and programmes aimed at the prevention of violence 
against women [11,19-25].
Infections during pregnancy can cross into the intra-
amniotic cavity, establish intra-amniotic infection and 
result in preterm labour. In some women, such infections 
are associated with premature rupture of the membranes 
[6]. Screening for and treatment of infections such as 
asymptomatic bacteriuria and bacterial vaginosis during 
antenatal care may reduce preterm births, although study 
ﬁ ndings show inconsistent results. Systematic reviews 
and meta-analyses show that antibiotic treatment for 
infection and periodontal care does not reliably reduce 
the risk of preterm birth, and eﬀ ectiveness may depend 
upon when during pregnancy the infection or periodontal 
disease is detected and treated. Th ree hypotheses have 
been proposed to explain the inconsistent ﬁ ndings of the 
eﬀ ect of antibiotic treatment on reducing preterm delivery: 
1)  infections may be polymicrobial in nature and even 
broad spectrum antibiotics may not be suﬃ  cient to treat 
them all, 2)  infections may not be the primary cause of 
preterm labour, and underlying [21,22] immuno sup-
pressive conditions may be responsible for inducing 
alternate biomolecular pathways leading to preterm 
labour. Th erefore, treating the bacterial infection alone 
may not be suﬃ  cient, and 3)  clinical signs of infection 
based on immune biomarkers are not true indicators of 
infection due to heterogeneity in inﬂ ammatory markers 
of various intra amniotic pathogens. More research is 
needed on the inter-relationships between infection, 
pregnant women’s immune response, and the cascade of 
events resulting in preterm birth [26]. Such research can 
inform the development of optimal screening and treat-
ment protocols based on underlying risk factors that will 
take into consideration when in pregnancy, or prior to 
pregnancy, screening and treatment for infections should 
occur to reduce the preterm birth rate [15].
Th e advantages of prophylactic treatment for malaria 
(intermittent presumptive treatment during pregnancy 
for malaria [IPTp]) and the use of bednets to prevent 
malaria transmission in malaria-endemic areas on reduc-
ing preterm birth similarly needs further investigation. 
More rigorous studies examining the impact of HIV 
infection and the use of antiretrovirals and TB medica-
tion during pregnancy on the risk of preterm birth that 
control for disease stage and other potential confounding 
factors are also needed [2].
Women’s nutritional status during pregnancy has been 
linked to preterm birth, with underweight and obese 
pregnant women at elevated risk of preterm birth and 
other poor obstetrical outcomes [6,27]. Malnutrition 
increases vulnerability to infection and predisposes preg-
nant women to adverse obstetrical outcomes including 
preterm delivery, although ﬁ ndings on obesity and the 
risk of preterm birth are mixed. Recent research suggests 
that the association between body mass index (BMI) and 
risk of preterm birth may diﬀ er by race or ethnic group, 
underscoring the complexity of the role nutrition plays in 
triggering preterm birth [28]. Providers can administer 
nutritional supplements and counselling services during 
routine antenatal visits. Evidence from clinical trials to 
date does not, in general, show a clear beneﬁ cial eﬀ ect of 
nutritional counselling, or protein and calorie supple-
ments during pregnancy on the preterm birth rate. A 
small eﬀ ect on reducing preterm births has been found 
from the use of multiple micro-nutrient supplementation, 
and evidence suggests that calcium supplementation 
during pregnancy can reduce the incidence of preterm 
births in populations at risk of low calcium uptake [11]. 
New ﬁ ndings also suggest a link between supplemen-
tation of docosahexaenoic acid (DHA) and overall greater 
gestation duration and infant size [29]. Further research 
is needed to determine the optimal timing during a 
woman’s life course of introducing nutritional interven-
tions for reducing the risk of preterm birth and how best 
to implement these interventions within the broader 
context of eﬀ orts to improve the overall nutritional status 
of pregnant women and women of reproductive age. 
Pregnant women should be encouraged to take multi-
v itamin supplements and to gain an adequate amount of 
weight based on their nutritional status at the beginning 
of their pregnancy, and for other health-promoting 
reasons such as reducing the risk of small for gestational 
age babies and neural tube defects.
Antenatal care services for prevention of preterm births, 
women at higher risk
Women at increased risk of preterm delivery can be 
identi ﬁ ed during antenatal care based on obstetric his-
tory (e.g., known uterine or cervical anomaly or previous 
preterm birth, pre-existing conditions such as chronic 
diseases) or presenting pregnancy characteristics (e.g., 
hypertensive disorder of pregnancy, diabetes, multiple 
gestation, bleeding). Young adolescents also are at greater 
risk [30,31]. Although prospective studies that evaluate 
the use of risk-screening tools based on epidemiologic, 
demographic biomarkers and clinical indicators in 
routine antenatal care are still needed, there are several 
approaches for providing preventive care for these 
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women. One such approach includes specialized ante-
natal clinics for women with evident risk of preterm birth 
that provide enhanced health education, and more 
rigorous monitoring and treatment of risk factors and 
pregnancy complications. Th e evidence is scanty on such 
approaches in reducing the risk of preterm birth, but 
trials were conducted prior to the introduction of new 
screening tests. Another approach involves adopting the 
principles of personalized medicine that includes 
tailoring interventions to match each individual woman’s 
risk proﬁ le.
Administration of progesterone to prolong pregnancy 
in high-risk women with a history of previous preterm 
birth has been shown eﬀ ective in preventing a recurrence 
of preterm birth in these women and in decreasing the 
prevalence of low birthweight [2]. A recent clinical trial, 
however, found no advantage to vaginal progesterone 
therapy at 200 mg or 400 mg doses in the prevention of 
preterm birth in twin pregnancies [32]. Recent guidelines 
and professional opinion recommend administering 
vaginal progesterone to women with singleton pregnan-
cies and short cervical length to reduce preterm birth 
and perinatal morbidity and mortality [33]. Most studies 
to date on the use of progesterone have been conducted 
in high-income countries. Th ere is a need for evidence 
generation on progesterone use in resource-constrained 
settings including how this intervention can be scaled up 
at national level and the feasibility of introducing 
universal cervical length measurement screening.
Cochrane reviews have shown small reductions in 
preterm birth rates with treatment interventions for pre-
eclampsia such as calcium supplementation. A recent 
randomized controlled trial has shown promising results 
for the use of a cervical pessary to lower rates of 
spontaneous preterm birth among women with a short 
cervix [34]. Results from another randomized controlled 
trial did not ﬁ nd any reductions in poor perinatal 
outcomes from use of a cervical pessary for prevention of 
preterm birth in women with a multiple pregnancy [35]. 
Another promising intervention in reducing the risk of 
preterm birth that requires further investigation is the 
placement of circumferential stitches on a structurally 
weak cervix (cerclage) [2,3].
Th ese interventions are only applicable to a small 
number of high-risk women, however, and the overall 
eﬀ ect on general population rates of preterm birth is 
likely to be limited.
Management of women in preterm labour to improve 
survival chances of the premature baby
Once preterm labour has commenced, there are 
interventions that can prolong pregnancy and improve 
health outcomes and survival for the premature baby. To 
date, these interventions have not been designed to 
address the underlying mechanisms that trigger preterm 
labour.
Interventions to prolong pregnancy include the pro-
vision of tocolytic agents that inhibit uterine contrac tions 
to suppress labour (e.g.,  oxytocin antagonists, beta mi-
metics, calcium channel blockers, magnesium sulphate), 
and clinical practices to ensure the optimal timing of 
caesarean birth and labour induction for indicated 
preterm births [2,9,15]. Th e provision of tocolytics has 
been shown eﬀ ective in slowing down labour, enabling 
the administration of antenatal cortico steroids and transfer 
of mother and baby to a higher-level facility where 
appropriate care may be available. Any use of strategies 
to prolong labour, including delaying caesarean birth, 
must be evaluated against the potential risk of continued 
exposure of mother and fetus to sub-optimal conditions 
that may result in harmful eﬀ ects. Further research is 
needed on the short- and long-term health consequences 
for mother and baby from eﬀ orts to prevent preterm labour.
Th ere are three key interventions that can be delivered 
during the pregnancy period with evidence of eﬀ ective-
ness in improving health outcomes in babies born pre-
maturely, although none of these are eﬀ ective in reducing 
the incidence of preterm births: antenatal corticosteroids, 
antibiotics for pPROM, and magnesium sulphate.
Th e administration of antenatal corticosteroids to preg-
nant women at high risk of preterm birth possibly as 
early as 23 weeks can signiﬁ cantly reduce the premature 
baby’s risk of death, respiratory distress and develop-
mental problems (Figure 1) [8].
Preterm premature rupture of the membranes (pPROM) 
is strongly associated with infection of the amniotic 
membranes contributing to preterm birth and other poor 
fetal outcomes such as cerebral palsy and chronic lung 
disease. It is unclear if infection is a cause or consequence 
of pPROM. Th e incidence of pPROM has not measurably 
changed in the past 40 years, and there are currently no 
screening or diagnostic markers because the mechanisms 
responsible for a large proportion of pPROM cases are 
still poorly understood. Antibiotic treatment for pPROM 
has been shown to delay onset of labour for up to 
48 hours and to reduce neonatal infections and abnormal 
cerebral ultrasound scans prior to hospital discharge [10]. 
Clinical management of pPROM including duration of 
administration of antibiotic prophylaxis depends upon 
the maternal-fetal condition, and other factors need to be 
considered such as timing of administration of antenatal 
corticosteroids and delivery.
Th e administration of magnesium sulphate to women 
at risk of preterm birth helps to protect the baby’s brain, 
reduce rates of cerebral palsy and improve long-term 
neonatal health outcomes. Further studies are needed, 
however, to investigate side eﬀ ects of the treatment for 
the mother (e.g.,  ﬂ ushing, sweating, nausea, vomiting, 
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Figure 1. Antenatal corticosteroids. Source: Born Too Soon report [1].
Evidence from more than 20 clinical trŝĂůƐĂŶĚĂĚĚŝƟŽŶĂůƐƚƵĚŝes in middle-incomeĐŽƵŶƚƌŝesƐƵĐŚĂƐBrĂǌŝů͕:ŽƌĚĂŶ͕^ŽƵƚŚĨƌŝĐĂĂŶĚdƵŶŝƐŝĂ
ŝŶĚŝĐĂƚĞƚŚĂƚĂŶƚĞŶĂƚĂůĐŽƌƟcosteroids administered to pregnant women at high risk of preterm birth is a highly eīeĐƟǀe and ƐĂĨĞŝŶƚĞƌǀĞŶƟŽŶ
ĨŽƌƌĞĚƵĐŝŶŐŶĞonatal mortality [ϲϲ͕ϲϳͲϳϭ΁͘ƐƵmmary of the trial data shows a ϯϰйƌĞůĂƟǀĞƌĞĚƵĐƟon in the incidence of respiratory distress 
syndrome (riƐŬƌĂƟo [RR] 0.66, 9ϱйĐŽŶĮdence interval [CI] 0.59–0.73), a 46% relaƟve reĚƵĐƟon in intraventricƵůar haemorrhage (RR 0.54, 95% 
CI 0.43–0.69) anĚĂϯϭйƌĞůĂƟǀĞƌĞĚƵĐƟŽŶin neonatal mortality (RR 0.69, 95% CI 0.ϱϴʹϬ͘ϴϭͿ͘^ŝŵŝůĂƌĮŶĚŝŶŐƐǁĞƌĞ recorded in the stƵĚies 
ĐĂƌƌŝĞĚŽƵƚŝŶůoǁͲĂŶĚŵŝĚĚůĞͲŝŶĐŽŵĞĐŽƵŶƚƌŝĞƐ͘dŚĞƌĞƐƵůƚƐƐƵggest that for every 100 women treated appropriately with antenatal 
ĐŽƌƟĐŽƐƚĞƌŽŝĚƐ͕ 4 neonatal deaths, 9 cases of RD^͕ϰŝŶƚƌĂǀĞŶƚƌŝĐƵůĂƌŚĂĞŵŽƌƌŚĂŐĞƐĂnd 12 cases ŽĨƐƵƌĨĂĐƚĂŶƚƵsĞǁŽƵůĚďĞĂǀŽided. 
 
ŶĂŶĂůǇƐŝƐƵƐŝŶŐƚŚĞ>ŝǀĞƐ Saved Tool shows that achievement ŽĨƵŶiversal (95%) coveƌĂŐĞŽĨĂŶƚĞŶĂƚĂůĐŽƌƟcosteroids across the 75 
ŽƵŶƚĚŽǁŶƚŽϮϬϭϱƉƌŝŽƌŝƟĞƐĐoƵŶƚƌŝĞƐǁŽƵůĚƌĞƐƵůƚŝŶĂŶĂƉƉƌoximate 40% decrease in preterm-associated mortality in 2015 — translaƟng to 
ĂƌŽƵŶĚϯϳϯ͕ϬϬϬĚĞĂƚŚƐĂverted per year in comparison to 2010 levels [72]. 
 
The WHO lists aŶƚĞŶĂƚĂůĐŽƌƟcosteroids as a priority interveŶƟon for the prevenƟon of respiratory distress syndrome in prematƵre babies, and 
considers antenatal corƟcosteroids (both betamethasone and dexamethasone) as a prioriƚǇŵĞĚŝĐŝŶĞĨŽƌƌĞĚƵĐŝŶŐŵŽƌƚĂůŝƚǇĂŵŽŶŐbabies 
born too early (PMNCH, 2011). Dexamethasone isŝŶĐůƵĚĞĚŽŶƚŚĞt,KĞƐƐĞŶƟĂůŵĞĚŝĐŝŶĞƐůŝƐƚ͕ďƵƚĂƚƚŚĞƟŵĞŽĨƉƵďůŝĐĂƟŽŶƚŚŝs is for 
treĂƟng allergies only [73]. 
 
Use in low- and middle-income countries – A need for scale up  
ltŚŽƵgh the evidence of the eīecƟveness of antenatal coƌƟcosteroids was established more than 15 years ago,ƵƐĂŐe rates remain 
ƵŶĂĐĐĞƉƚĂďůǇůŽǁ͘/ŶϮϬϬϬ͕ŝƚǁaƐĞƐƟŵĂƚĞĚƚŚĂtŝŶƚŚĞϰϮĐŽƵŶƚƌŝĞƐ with 90% of the worldwide childhood deaths, only 5% of appropriate 
candidates received the intervenƟŽŶ΀ϳϰ΁͘ŶŽƚŚĞƌƐƚƵĚǇďased on ĚĂƚĂĨƌŽŵϳϱĐŽƵŶƚƌŝes esƟŵĂƚed that only 10% of eligible mothers 
received antenatal corƟcosteroids [75]. In>ĂƟŶ ŵĞƌŝĐĂ͕ƐŝǆƐƚƵĚŝĞƐbetween 1999 and 2009 reported that the Ƶse of antenatal coƌƟcosteroids 




To date, all trials have been cŽŶĚƵcted in hospital seƫngs, most of them referral faciliƟes with availability of high-level care (oxygen, 
ŝŶĐƵďĂƚŽƌƐ͕ĂŶĚǀĞŶƟůĂƚŽƌƐͿ͘dŚĞŶĞǆƚƐƚĞƉŝƐƚŽassess the ĞīĞct of antenatal coƌƟcosteroids on maternal and neonatal health in lower-level 
faciliƟes or home births where no specialized care is available at childbirth. Research is also needed on barriers and facilitaƟng factors to the 
ĂƉƉƌŽƉƌŝĂƚĞĂĚŵŝŶŝƐƚƌĂƟŽŶŽĨantenatal coƌƟĐŽƐƚĞƌŽŝĚƐ͘D,/WŝƐĐŽŶĚƵĐƟŶŐĂƐŵĂůůŽƉĞƌĂƟŽŶƐƌĞƐĞĂƌĐŚƐƚƵĚǇiŶƚŚƌĞĞĐŽƵŶƚƌŝesŝŶƐŝĂ
(Indonesia, Philippines, and Cambodia) to assess the evidence arŽƵŶĚƚŚĞƵse of anƚĞŶĂƚĂůĐŽƌƟĐŽƐƚĞƌŽŝĚƐŝŶŚŽƐƉŝƚĂůƐĞƫŶŐƐ͘  ReƐƵůƚs are 
expected in late ϮϬϭϰ;ƉĞƌƐŽŶĂůĐŽŵŵƵŶŝĐĂƟŽŶǁŝƚŚƌ͘&ĞƌŶĂŶĚŽůƚŚĂďĞĂŶĚ JHPIEGO).  
 
Lessons learned – an implementaƟŽŶ agenda 
In the United States, low providerƵƐe of antenatal corƟcosteroids 20 years ago was ƐƵĐĐĞƐƐĨƵůůǇ addressed throƵgh the development of a 
ŵƵlƟfaceted interveŶƟon inclƵĚing informing local opinion leaders, the iŶƚƌŽĚƵĐƟon ofƚŚĞŝŶƚĞƌǀĞŶƟŽŶŝŶƚŽclinical grand rŽƵŶĚƐ͕ĐŚĂƌƚ
reminders, groƵƉĚŝƐĐƵƐƐŝŽŶƐ͕ĂŶĚĂƵĚŝƚĂŶĚĨeedďĂĐŬƉƌĂĐƟĐĞƐ΀ϴϭ΁͘t,KĐŽŶĚƵĐƚĞd a trial in 22 hospitals in Mexico and 18 hospitals in 
Thailand to evĂůƵĂƚe theĞīeĐƚŽĨĂŵƵůƟĨĂĐeted eĚƵĐĂƟŽŶĂůƐƚƌĂƚĞŐǇƚŽƉƌŽŵŽƚĞƚŚĞƵƐĞof the WHO ReprŽĚƵcƟve Health >ŝďrary 
(Development aŶĚZĞƐĞĂƌĐŚdƌĂŝŶŝŶŐŝŶ,ƵŵĂŶZĞƉƌŽĚƵĐƟŽŶ͕Ϯ012) on several obstetric ƉƌĂĐƟĐeƐ͕ŝŶĐůƵĚŝŶŐƚŚĞƵƐĞŽĨantenatal 
ĐŽƌƟcosteroids in preterm births at less than 34 weeks geƐƚĂƟon. The reƐƵlts showed no changes in the lowƵƐe of antenatal coƌƟcosteroids in 
these hospitals [82]. TheĮndings of the WHO stƵĚyƐƵggest that eĚƵĐĂƟŽŶĂůŽŶĞŝƐŶŽƚĞŶŽƵŐŚƚo change clinical ƉƌĂĐƟĐĞ͘/ŶƐtead, 
interveŶƟons need to be designed that combine training with appropriateƐƵƉervision and clinic reminders. In low- and middle-income 
ĐŽƵŶƚƌŝĞƐ͕ŝŵƉůemĞŶƚĂƟŽŶƐƚƌĂƚĞŐŝĞƐƚŚĂƚĂĚdreƐƐƐƵpply-cŚĂŝŶƉƌŽďůĞŵƐŵƵƐƚ also beƉƌŝŽƌŝƟǌĞĚƚŽƌĞĚƵĐĞŽĐĐƵƌƌĞŶĐĞŽĨƐƚŽĐŬͲŽƵƚƐ͘
  
/ŶƌĞĐŽŐŶŝƟŽŶŽĨƚŚĞŵĂŶǇĐŚĂůůenges relateĚƚŽƚŚĞƵƉƚĂŬĞŽĨproven interveŶƟonƐƐƵch as antenatal corƟcosteroids, the United NaƟons 
established a CoŵŵŝƐƐŝŽŶŽŶ>ŝĨĞƐĂǀŝŶŐŽmmoĚŝƟĞƐĨŽƌtŽŵĞŶĂnd Children in 2012. The Commission has reviewed recommĞŶĚĂƟŽŶƐfor 
addressing the sƵƉƉůǇͲĐŚĂŝŶ͕ƚƌĂŝŶŝŶŐƌĞƋƵŝƌĞŵĞntƐ͕ĂŶĚŽƚŚĞƌŝŵƉůĞŵĞŶƚĂƟŽŶďĂƌƌŝĞƌƐĨĂĐĞĚďǇůŽǁͲĂŶĚŵŝĚĚůĞͲŝŶĐŽŵĞĐŽƵŶƚƌŝĞƐ in their 
ĞīŽƌƚƐƚŽƐĐĂůĞƵƉĂŶƚĞŶĂƚĂůĐŽƌƟcosteroids (the aims of the Commission are descriďĞĚŝŶƚŚŝƐƐƵpplement) [73]. The 66th World Health 
ƐƐĞmbly approved a reƐŽůƵƟŽŶŽŶƚŚĞŽŵŵŝƐƐiŽŶǁŚŝĐŚƵƌŐĞƐĐŽƵŶƚƌŝĞƐƚŽŝŵƉƌŽǀĞƚŚĞƋƵality, ƐƵƉƉůǇ͕ĂŶĚƵse of the 13 life-saving 
ĐŽŵŵŽĚŝƟĞƐŝĚĞŶƟĮĞĚďǇƚŚĞommission, and asŬƐt,KƚŽǁŽƌŬǁŝƚŚĐŽƵŶƚƌŝĞƐĂŶĚŝƚƐpartners ƚŽƐƵƉƉŽƌƚƚŚĞŝŵƉůĞŵĞŶƚĂƟŽŶŽĨ the 
ŽŵŵŝƐƐŝŽŶ͛ƐƌĞĐŽŵŵĞŶĚĂƟŽŶƐ [83]. 
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headaches and a rapid heartbeat) and how these can be 
reduced [20].
Section II. Avenues for intervening to improve the 
broader context
Th is section describes opportunities to intervene at the 
community and policy levels to ensure a supportive 
environment for pregnant women.
Behaviour and community interventions for the 
prevention of preterm birth
Lifestyle factors including depression, intimate partner 
violence, smoking, substance abuse and stress are risk 
factors for preterm birth. Antenatal care models, 
including group models, that address these issues and 
provide social and ﬁ nancial support for pregnant women 
and particularly disadvantaged/at-risk population groups 
have been associated with reduced rates of preterm birth 
[36,37]. Th ere are numerous eﬀ orts underway to deter-
mine how best to integrate psychological and behavioural 
interventions, including programmes to prevent violence, 
into antenatal care to improve preterm birth rates and 
other maternal and neonatal health outcomes. Controlled 
trials need to be designed to further test the eﬃ  cacy of 
antenatal care approaches that incorporate social and 
ﬁ nancial support measures so that such approaches can 
be introduced at scale in settings where they are most 
needed. A recent systematic review and meta-analysis on 
the eﬀ ects of women’s groups practicing participatory 
learning and action showed that these strategies are a 
cost-eﬀ ective approach to improving maternal and 
neonatal health outcomes [38]. More research is needed 
on how women’s empowerment approaches can translate 
into reduced preterm birth rates.
Smoking during pregnancy is a well-known cause of 
preterm birth, especially preterm birth complicated by 
pPROM. Smoking cessation interventions in high-income 
countries that combine counselling with additional social 
support services have been found to signiﬁ cantly reduce 
preterm birth and should be adapted for application in 
low- and middle-income countries where the large 
majority of smokers live [39]. Th ese approaches could 
prove to be more successful than large scale campaigns in 
changing women’s smoking habits during pregnancy. 
Greater understanding of the biomolecular pathways 
through which the chemicals in cigarette smoke trigger 
deleterious events during pregnancy could potentially 
lead to new interventions targeted at smokers unable to 
quit when pregnant.
Other programmes such as the Healthy Babies are 
Worth the Wait™ campaign of the March of Dimes and 
the “humanization of childbirth” social movement in 
Brazil and other Latin American countries that educate 
women with healthy pregnancies about the advantages of 
vaginal delivery and waiting until 39  weeks to deliver 
should be promoted, particularly in contexts charac ter-
ized by high and rising elective caesarean birth rates 
[40,41]. Health care provider education on the adverse 
health outcomes of late preterm birth and of inducing 
birth for non-medical reasons prior to 39 weeks has been 
shown to be eﬀ ective in reducing preterm birth rates in 
some countries such as Brazil [40,42,43].
Policy interventions to promote healthy pregnancies
Pregnant women can experience a reduced risk of 
preterm birth and other health beneﬁ ts from professional 
and public policies based on sound scientiﬁ c evidence. 
Blencowe and colleagues show that the risk of preterm 
birth increases in women with twins and higher-order 
births [12]. Policies on infertility treatments and use of 
assisted reproductive technologies directed to limiting 
the number of embryos that can be transferred have 
shown success in reducing the number of higher-order 
births and the associated high risk of preterm birth in 
Europe, Australia and the United States [15,44,45].
Hospital policies aimed at lowering the primary 
caesarean birth rate and early induction rates, particularly 
for non-medically indicated reasons, are part of a 
growing eﬀ ort to prolong pregnancy, promote healthy 
newborn outcomes and reverse the increasing trend of 
preterm birth. Such policies are especially needed in 
regions where caesarean birth rates, and particularly 
elective caesarean birth rates, are high or rising like in 
Latin America and many high-income countries. Legis-
lation mandating universal access to maternal health care 
services and eliminating user fees in low- and middle- 
income countries also have been shown to be an important 
prerequisite to ensuring all women receive antenatal care.
Workplace policies designed to promote healthy preg-
nan cies and protect pregnant women from occupational 
hazards can potentially reduce the risk of preterm birth. 
Examples include, but are not limited to, time oﬀ  for 
antenatal care visits, paid pregnancy leave for a set 
number of weeks and exemption from night shifts and 
tasks requiring heavy lifting or standing for long periods 
of time [46]. Studies have shown that carrying heavy 
workloads and working more than 5  days a week are 
associated with preterm birth [47]. Measures that can 
improve general working conditions are especially im-
por tant for pregnant women in low- and middle-income 
countries where they are more likely to be engaged in 
agricultural labour and other physically demanding tasks.
Pregnant women can beneﬁ t from legislation reducing 
their exposure to potentially harmful environmental risk 
factors such as second-hand smoke and air pollution 
(combustion and household sources) [48]. Th ere is grow-
ing interest in understanding and developing policy and 
programmatic solutions to the association between air 
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pollution and adverse pregnancy outcomes including 
preterm birth [49-54]. For example, the UN Foundation 
houses the Global Alliance for Clean Cookstoves, a 
multi-partner eﬀ ort launched in 2010 to promote clean 
and eﬃ  cient cookstoves. Traditional cookstoves and 
open ﬁ res, the primary means of cooking and heating for 
nearly three billion people in the developing world, place 
pregnant women at increased risk of preterm birth and 
other poor obstetrical outcomes.
Section III. Limitations of the evidence
Th e clinical trial literature shows a lack of evidence for 
many of the preventive interventions currently in use. 
Th e multi-causal and complex nature of preterm birth is 
likely responsible for single interventions not showing a 
signiﬁ cant public health eﬀ ect and it is thus doubtful that 
rates of preterm birth can be reduced by the delivery of 
one single intervention. Th ere is, therefore, an imperative 
need for well-designed studies examining the eﬀ ective-
ness of interventions delivered alone or as an integrated 
package of antenatal care. Epidemiological research is 
needed to assess the eﬀ ectiveness of introducing a com-
pre hensive set of science-based interventions delivered at 
the policy, health system and community or home levels 
on reducing the rate of preterm birth. Th e scientiﬁ c 
literature and technical reports similarly show evidence 
for only a handful of interventions delivered during preg-
nancy that can improve the health outcomes of babies 
born too early, again stressing the need for more research 
on available and promising interventions. Th is emphasis 
on research and generation of quality data, however, needs 
to be balanced with the further promotion and worldwide 
scale up of interventions with proven eﬀ ectiveness.
Th e brevity of the list of interventions delivered during 
the pregnancy period with evidence of eﬀ ectiveness for 
preterm birth prevention and for improving survival 
chances of the premature baby is related to long-standing 
neglect of the newborn period and to insuﬃ  cient 
research on the biological complexities of pregnancy and 
childbirth. Th e growing concentration of child deaths in 
the newborn period and the emergence of organizations 
and eﬀ orts focused on the newborn (e.g.,  Th e Healthy 
Newborn Partnership in the mid-2000s, and Saving 
Newborn Lives) have served as a catalyst for focused 
attention on preterm birth, a leading cause of newborn 
mortality [55,56]. Th ere is an increasing emphasis on 
research that can inform the development of cohesive 
strategies for addressing the underlying determinants of 
preterm delivery with the goal of reducing the numbers 
of preterm births.
Section IV. An action agenda and next steps
Th is section describes opportunities to scale-up available 
eﬀ ective interventions, priority research themes to 
increase the evidence base on what works and how best 
to deliver proven interventions to reach all women with 
eﬀ ective care, and a set of action points that can be 
adopted by countries now depending upon resource 
constraints.
Program opportunities to scale up
Coverage of antenatal care (at least one visit) is approxi-
mately 80% worldwide, with coverage levels dropping to 
about 50% for four or more visits. Inequities in coverage 
are pervasive, with coverage levels of four or more ante-
natal care visits hovering around 40% for the least 
developed countries [18]. Th ese ﬁ gures indicate that 
eﬀ orts aimed at improving availability of antenatal care, 
demand for care and women’s ability to reach these 
services throughout the pregnancy period are needed, 
particularly in low-resource settings and amongst the 
most disadvantaged population groups. Adolescents are 
another group at high risk of preterm birth due to their 
young age and typically limited access to preconception 
and prenatal care [57].
Figure  2 shows median coverage of antenatal care 
services to pregnant women living in the Countdown to 
2015 priority countries where more than 95% of all 
maternal and child deaths occur [58]. Consistent with the 
global data, the ﬁ gure shows high levels of at least one 
visit of antenatal care across the Countdown countries, 
but considerably lower levels of the recommended four 
or more antenatal care visits. Th is indicates that the 
majority of women in these countries are not beneﬁ ting 
from the recommended basic package of antenatal care 
services. Th e ﬁ gure also highlights substantial gaps in the 
quality of care pregnant women are receiving during 
antenatal care visits, with coverage levels of speciﬁ c 
evidence-based interventions considerably lower than 
the ideal of universal coverage. A similar review of gaps 
in the provision of key components of antenatal care in 
sub-Saharan Africa, where the rates and absolute 
numbers of preterm birth are among the highest in the 
world, similarly showed low levels of coverage of several 
recommended components [59,60]. Th ese missed oppor-
tunities are a call to action for strengthening health 
systems in the Countdown priority and other low- and 
middle-income countries including ensuring practitioners 
are equipped with the skills and necessary drugs and 
equipment to deliver eﬀ ective antenatal care that can 
potentially reduce the risk of preterm birth and improve 
health outcomes of the premature baby.
Table 2 shows coverage levels of preterm birth-related 
interventions available from a World Health Organization 
multi-country study on the prevalence of maternal near-
miss cases with a key objective of mapping the use of 
evidence-based interventions during childbirth in health 
care facilities [61]. At the time of publication, 
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country-speciﬁ c data were available only for the Latin 
American countries involved in the study, and Mexico is 
presented as an example. Th e low coverage levels shown 
in Table  2 should serve as a startingpoint for dialogue 
with govern ments, development partners and health care 
providers in the study countries on developing strategies 
for in creasing the uptake of these science-based 
interventions.
Priority research themes for the pregnancy period and 
childbirth
Th ere is an imperative need for research on preterm birth 
that can yield quality data on the eﬃ  cacy of existing and 
promising interventions delivered individually or as a 
package during the pregnancy period. Th ere is an equally 
critical need for implementation research to improve the 
scale up of proven policy and health care interventions in 
low- and middle-income countries. Th ere has been 
increasing interest in preterm birth in recent years and in 
developing a comprehensive research paradigm to 
address this growing cause of neonatal mortality. A major 
emphasis of the paradigm has been on discovery science 
to shed light on the basic biology of normal and abnormal 
pregnancies so that the pathological process of preterm 
birth can be understood and eﬀ ective interventions 
developed. Th is research will also potentially result in the 
development of better screening tools for the prediction 
and prevention of preterm labour. Th e link between 
genetics, gene-environment interactions and preterm 
birth is being investigated with the hope of gaining an 
understanding of diﬀ erences in preterm birth rates across 
racial and ethnic groups that can be translated into more 
eﬀ ective and equitable clinical care guidelines including 
counselling and screening services [26,62]. Research is 
underway to explore the connections between maternal 
Figure 2. Median coverage of antenatal care services, Countdown to 2015 priority countries. Source: Born Too Soon Report [1]. Data source 
[1]: UNICEF Global Databases, February 2012, based on Demographic Health Surveys, Multiple Indicator Cluster Surveys and other national surveys. 
Note: Countdown to 2015 priority countries with available data, 2006-2010. Acronyms used: ANC = antenatal care; IPT = intermittent presumptive 
treatment.
Table 2. Coverage levels of key interventions, pregnant 
women in labour, 24 to 34 weeks, after 3 hours in the 
hospital, World Health Organization 18 country study
Intervention All countries* Mexico
Antenatal corticosteroids 56.4% 53.8%
Tocolytic agents
 Beta mimetics 15.8% 8.2%
 Calcium channel blockers 9.9% 7.7%
 Magnesium sulphate 7.8% 4.9%
 Oxytocin antagonists 1.2% 2.4%
*Countries include Afghanistan, Argentina, Cambodia, China, Ecuador, 
Japan, Kenya, Mexico, Mongolia, Nepal, Nicaragua, Pakistan, Paraguay, Peru, 
Philippines, Thailand, Sri Lanka and Vietnam.
Source: Born Too Soon report [1]. Data source: Souza et al., 2011. Preliminary 
results, World Health Organization, Multi-country survey on maternal and 
newborn health.
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infections, nutritional status and preterm birth within a 
broader framework of research on prematurity, low 
birthweight and intrauterine growth restriction (Figure 3). 
In addition, research on the social determinants of 
preterm birth is being conducted to explore the pathways 
between social disadvantage, behavioural and lifestyle 
factors and preterm birth [63-65]. A major goal of this 
research is to help develop strategies for addressing social 
and economic disparities in preterm birth rates, 
inequities in access to needed care between and within 
countries as well as how to best integrate social and 
behavioural interventions into antenatal care.
Figure  3 presents information on select ongoing 
research activities to generate the evidence needed to 




ďǇt,KŚĂǀĞ rĞƐƵůƚĞĚŝŶĐŽŶĐƌĞƚĞĂĐƟŽŶƐƚĞƉƐƚŽĮůůƐĞǀĞƌĂůŬŶŽǁůĞĚŐĞŐĂƉƐ͕ŝŶĐůƵĚŝŶŐ ĞƐƟŵĂƟŽŶŽĨƚŚĞ ŐůŽďĂůƉƌĞƚĞrŵďŝƌƚŚrĂƚĞ͕ ƐǇƐƚĞŵĂƟĐ
ƌĞǀŝĞǁƐ;Ğ͘Ő͕͘ŽŶŐĞŶĞƟĐŵĂƌŬĞƌƐ͕ďŝŽŵĂƌŬĞƌƐĂŶĚƌŝƐŬĨĂĐƚŽƌƐƐƵĐŚĂƐD/ͿĂŶĚ ŐƵŝĚĞůŝŶĞƐŽŶĐŽŶĚƵĐƟŶŐďĂƐŝĐĂŶĚĐůŝŶŝĐĂůƌĞƐĞĂƌĐŚ ŽŶƉƌĞƚĞƌŵ
ďŝƌƚŚ͘WZ/C ĞĚƵĐĂƟonĂůĂĐƟǀŝƟĞƐ ŝŶĐůƵĚĞ orŐĂŶŝǌŝŶŐ ƐĂƚĞůůŝƚĞƐǇŵƉŽƐŝƵŵƐŝŶĂƐƐŽĐŝĂƟoŶǁŝƚŚŵĂjor pĞƌŝŶĂƚĂůĂŶĚŽďƐƚĞƚƌŝĐĐonŐƌĞƐƐĞƐ͘ 
WZ/C ŝƐ ĞƐƚĂďůŝƐŚŝŶŐ rĞƐĞĂƌĐŚĐŽƌĞĐĞŶƚƌĞƐĂŶĚ ĐŽůůĂďŽƌĂƟŶŐǁŝƚŚŽƚŚĞƌŽƌŐĂŶŝǌĂƟŽŶƐƚŽƐĞƚƵƉ ĚĂƚĂĂŶĚďŝŽůŽŐŝĐĂůƐĂŵƉůĞƌĞpoƐŝƚorŝĞƐƚo 
ĨƵƌƚŚĞƌƉƌŽŵŽƚĞƉƌĞƚĞƌŵďŝƌƚŚƌĞƐĞĂƌĐŚ͘ 
 
The Preterm Birth Genome Project (PGP) ŝƐĂŵƵůƟŶĂƟŽŶĂůĐoůůĂďoƌĂƟǀĞƐƚƵĚǇŽĨ ŐĞnĞ-ĞŶǀŝƌŽŶŵĞŶƚŝŶƚĞƌĂĐƟŽŶƐŝŶƐƉŽŶƚĂŶĞŽƵƐprĞƚĞƌŵďŝƌƚŚ
ƚŚĂƚŝƐƉĂƌƚŽĨWZ/ĂŶĚĂŝŵƐƚoŝĚĞŶƟĨǇŐĞnĞƐƚŚĂƚŝŶĐƌĞĂƐĞƐƵƐĐĞƉƟďŝůŝƚǇƚŽƉƌĞƚĞƌŵďŝƌƚŚ͕ƵƐŝŶŐŐĞŶŽŵĞͲǁŝĚĞĂƐƐŽĐŝĂƟŽŶĂƐĂn ŝŶŝƟĂůƚŽŽů͘ 
dŚĞƉƌŽũĞĐƚŝŶǀŽůǀĞƐĂ ĮǀĞǇĞĂƌĮǀĞͲƉŚĂƐĞƌĞƐĞĂrĐŚƉůĂŶŝŶĐůƵĚŝnŐĂǁŚŽůĞŐĞnoŵĞĂŶĂůǇƐŝƐƚŽĚĞƚĞƌŵŝŶĞŐĞŶĞƟĐǀĂƌŝĂŶƚƐĂƐƐŽĐŝĂƚĞĚǁŝƚŚ
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inform the development of eﬀ ective preventive pro-
grammes and policies. Table  3 summarizes the key 
interrelated areas of priority research on preterm birth in 
the pregnancy period, emphasizing that simultaneous 
progress in each of these areas is critical for achieving 
reductions in preterm birth rates and optimal birth 
outcomes for the premature baby.
Prescription for action during the pregnancy period and 
childbirth
A standard approach to preterm birth prevention during 
the pregnancy period hinges upon the ﬁ ndings of the 
ongoing research on the causal pathways to preterm 
delivery. Clinical management practices will need to 
remain ﬂ exible as practitioners decide upon a course of 
action based on the particular characteristics and set of 
risk factors of their individual women clients. Th ere are, 
however, basic steps that countries around the world can 
introduce now and as resources permit to begin making 
strides towards addressing this growing public health 
problem. Th ese steps are summarized in Table  4 and 
described in more detail below.
As a ﬁ rst step, national policies and guidelines for com-
prehensive antenatal, labour and delivery, emergency 
obstetric and postnatal care should be established in all 
countries to promote universal access to quality maternal 
and perinatal services. Pro-poor legislation (e.g.,  to 
abolish user fees, introduce conditional cash transfer 
programmes, etc.) for maternal and perinatal services 
should be considered in low- and middle-income coun-
tries where out-of-pocket expenses are high and/or 
coverage levels of antenatal and delivery care inter ven-
tions are low. Protective legislation is needed to improve 
general working conditions for pregnant women, and to 
reduce pregnant women’s exposure to potentially harmful 
environmental, behavioural and lifestyle risk factors such 
as second-hand smoke and violence against women.
Th e implementation of national and professional 
policies and guidelines that are in-line with science-based 
recommendations, such as those made by WHO, needs 
to be prioritized. All countries and their partners should 
allocate suﬃ  cient resources to strengthening health care 
systems to facilitate the implementation process and 
enable the equitable and early delivery of quality 
antenatal care. Resources also are needed to develop 
clearly deﬁ ned care and referral pathways. Prevention 
needs to be prioritized through improving access to 
screening and diagnostic tests and appropriate treatment 
during antenatal care with adequate follow-up and 
referral of women identiﬁ ed at high risk of preterm birth.
Eﬀ orts to strengthen health systems must include 
increased and regular training opportunities for health 
Table 3. Research priorities during pregnancy to reduce preterm birth rates and to benefi t the preterm baby
Description
Epidemiological research to:
• Examine the relationships between maternal risk factors and preterm birth at a population level (e.g., nutritional, infection, age and other socio-
demographic factors)
Discovery
Basic science research on normal and abnormal pregnancies to:
•  Identify the causal pathways leading to preterm labour and birth
•  Understand the gestational clock triggering the onset of labour
•  Explore the genetic determinants of preterm birth and genetic-environment interactions increasing risk of preterm birth
Development
Translational research to:
•  Develop simple screening tools based on the fi ndings of biological and genetic research for identifying women at high risk of preterm birth and 
preterm labour
•  Develop robust diagnostic tools for universal application (e.g., anaemia, syphilis)
Delivery
Clinical trials and other studies to:
•  Build the evidence base on available and promising interventions
•  Determine effectiveness of interventions delivered individually and as packages of care
Implementation research to:
•  Address coverage gaps by increasing the availability of antenatal care and women’s ability to access services around the world
•  Address quality of care gaps by increasing the uptake of evidence-based interventions and intervention packages by health care providers (e.g., 
syphilis testing and screening, blood pressure monitoring during antenatal care visits, etc.)
Source: Born Too Soon report [1].
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care providers on the use of eﬀ ective interventions, and 
on tailoring clinical care to the individual woman based 
on her risk proﬁ le throughout the duration of her preg-
nancy. Th e delivery of all recommended components of 
antenatal care should be regularly instituted and 
monitored through supportive supervision.
Th ese health care system readiness eﬀ orts need to be 
complemented by communication and education cam-
paigns to increase demand for maternal and perinatal 
care services and to ensure prospective parents and 
community members are fully informed about a healthy 
pregnancy and potential complications.
In settings with greater capacity, professional policies 
regulating assisted reproductive technologies and infer-
tility treatments should be put into place to reduce the 
number of multiple gestations at higher risk of preterm 
birth. Genetic counselling and adequate counselling for 
women over the age of 35 on pregnancy risks also should 
be included as components of antenatal care.
All women should be provided with access to quality 
antenatal care services and a functional referral system 
throughout pregnancy. Women should be encouraged to 
give birth in healthcare facilities and have access to health 
care facilities where quality maternal services are 
guaranteed. Community members need to be informed 
about the importance of all women receiving antenatal 
care and delivering in functioning health care facilities as 
well as warning signs in pregnancy including preterm 
labour. In low- and middle-income countries, commu-
nities need to be supported in developing appropriate 
mechanisms that enable women to seek care, particularly 
the most disadvantaged women who face multiple 
barriers to accessing timely care.
Th e integration of eﬀ ective services should be promoted 
to best use antenatal care visits as a platform for the 
delivery of a package of interventions and to leverage 
scarce resources for women’s and children’s health. Th e 
integration of HIV, malaria, and social and ﬁ nancial 
support programmes into routine antenatal care, for 
example, represents an eﬃ  cient use of resources with 
potential to reach a large majority of pregnant women.
Health care facilities need to be equipped with trained 
staﬀ  and ample and consistent supplies of drugs and 
equipment so that women can be guaranteed provision of 
antibiotics for pPROM, antenatal corticosteroids, proges-
terone, magnesium sulphate and tocolytics as needed.
Countries need to engage in collaborative and multi-
center research for the development of high-quality evi-
dence on available and promising interventions delivered 
singly and as a package during antenatal care or labour 
and delivery. Adequate funding is needed for basic 
science research on the etiology of preterm birth, the 
physiological processes of healthy and abnormal 
pregnancies and the linkages between preterm birth and 
genetics, environment, stress and depression, infection 
and nutrition. Findings from such research will guide the 
development of preventive interventions, diagnostic 
markers and related screening tools and better clinical 
management guidelines for all women and for women at 
high risk of preterm birth. Th ese cross-country, multi-
disciplinary research eﬀ orts will ultimately facilitate the 
discovery and development of interventions with 
universal application.
Implementation research is essential for determining 
how research ﬁ ndings can be best translated into prac-
tical application in low- and middle-income countries 
Table 4. Actions during pregnancy to prevent or manage preterm birth
Invest and plan
•  Ensure national policies and guidelines exist and provide adequate protection of pregnant women and universal access to comprehensive antenatal, 
labour and birth, emergency obstetric and postnatal care.
•  Allocate adequate resources for the provision of equitable and high-quality antenatal care, and removal of barriers to care such as user fees.
Implement
•  Seize opportunities to leverage resources, approaches, and training opportunities from existing programmes (including non-health programmes)
•  Ensure the existence of a functional referral system, procurement system, an adequately trained and supervised health work force, and quality services 
for all pregnant women. Inform communities about the importance of antenatal, childbirth and postnatal care for all women, and warning signs 
including early recognition of preterm labour.
Inform and improve programme coverage and quality
•  Address data gaps and increase sound monitoring and evaluation of programmes to improve service quality and outreach to the poorest 
populations.
•  Prioritize implementation research to promote the scale up of effective interventions in different contexts and across different population groups.
Innovate and undertake implementation research
•  Invest in discovery research on the basic biology of normal and abnormal pregnancy, genetic determinants of preterm birth, and epidemiological 
research on maternal risk factors to provide the evidence base needed for the development of effective prevention and treatment strategies.
We all share in the responsibility of making sure pregnant women around the world receive the care they need for healthy birth outcomes.
Source: Born Too Soon report [1].
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where resource constraints and inequities in intervention 
coverage are more pronounced and where innovations in 
service delivery strategies are most needed. Eﬀ orts are 
needed, for example, on how to most eﬀ ectively integrate 
evidence-based interventions into antenatal care in 
speciﬁ c contexts so that pregnant women are reached 
with comprehensive and culturally appropriate packages 
of care.
National audit and other monitoring and evaluation 
systems at facility level need to be put into place as a 
quality control measure to track preterm birth rates and 
the use of eﬀ ective services during antenatal care and 
labour and delivery.
In all settings, ongoing monitoring and evaluation of 
the implementation of guidelines and policies are 
essential for ensuring that pregnant women receive high-
quality care based on the best evidence.
Conclusion
Th e pregnancy period is a time of great excitement for 
prospective parents. It represents a time period when a 
woman can be reached through a variety of mechanisms 
with interventions aimed at reducing her risk of a 
preterm birth and improving her health and the health of 
her unborn baby. One key mechanism is routine ante-
natal care during which a woman should receive a range 
of eﬀ ective services at multiple times throughout her 
pregnancy that are tailored to her individual risk proﬁ le. 
She also can beneﬁ t from supportive policies and 
programmes that increase her access to quality care and 
protect her from potentially harmful exposures. Th e 
message is clear: We all need to work together to make it 
possible for women everywhere to receive the care they 
need during pregnancy, labour and delivery as a starting 
point for successfully addressing the growing problem of 
preterm birth.
Th is involves simultaneous and coordinated action in 
the three main areas of service delivery, discovery and 
development. Although there are substantial gaps in our 
knowledge of the underlying causal pathways of preterm 
labour and delivery, we know there are proven inter-
ventions that need to be scaled up now. Governments 
and their partners must prioritize the equitable delivery 
of these interventions through innovative and cost-
eﬀ ective strategies. At the same time, basic research and 
discovery science must be promoted to build the 
evidence base so that eﬀ ective preventive and treatment 
inter ventions can be designed. Th is will require colla-
bora tive partnerships across institutions and countries. 
As the evidence is generated, resources need to be 
allocated to its translation into new and better screening 
and diagnostic tools and other interventions aimed at 
saving maternal and newborn lives. Th e time is now to 
put this action plan into motion.
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